Psoriatic arthritis is a heterogeneous condition, the pattern of which is determined by any combination of pathology affecting peripheral joints, the enthesis and the spine. There is a paucity of evidence for most of the conventional agents used to treat psoriatic arthritis, with many of them being used on the basis of experience in rheumatoid arthritis. Herein, we summarise the evidence compiled relating to effectiveness of treatment for various manifestation of PsA. For those patients with progressive forms of arthritis who may benefit from intervention of newer biological therapies, the continued use of conventional therapy needs ever increasing scrutiny. Key words: Psoriatic arthritis, psoriasis, therap
Psoriatic arthritis (PsA) is characteristically associated with a large spectrum of disorders, some ...
Skin and joint manifestations associated with psoriasis and psoriatic arthritis (PsA) can significan...
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, wh...
Psoriatic Arthritis (PsA) is a chronic inflammatory disease typically characterized by arthritis and...
OBJECTIVES: Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy characterized by the ass...
The development programmes of different TNF-blocking agents in psoriatic arthritis (PsA) not only pr...
Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and pre...
Psoriatic arthritis (PsA) is a chronic systemic inflammatory disease characterized by joint inflamma...
Psoriatic arthritis (PsA) is a chronic inflammatory disease that can be progressive and may be assoc...
Objective: To develop comprehensive recommendations for the treatment of the various clinical manife...
Recent advances in the therapeutics of psoriatic arthritis (PsA) have provided more options to clini...
As erosive and deforming arthritis is present in 40% of patients with psoriatic arthritis (PsA), ear...
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease with heterogeneous clinical presen...
Psoriatic arthritis (PsA) is a chronic inflammatory condition with articular and extra-articular man...
Psoriatic arthritis (PsA) is a chronic inflamma-tory arthropathy of the peripheral joints, spine, an...
Psoriatic arthritis (PsA) is characteristically associated with a large spectrum of disorders, some ...
Skin and joint manifestations associated with psoriasis and psoriatic arthritis (PsA) can significan...
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, wh...
Psoriatic Arthritis (PsA) is a chronic inflammatory disease typically characterized by arthritis and...
OBJECTIVES: Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy characterized by the ass...
The development programmes of different TNF-blocking agents in psoriatic arthritis (PsA) not only pr...
Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and pre...
Psoriatic arthritis (PsA) is a chronic systemic inflammatory disease characterized by joint inflamma...
Psoriatic arthritis (PsA) is a chronic inflammatory disease that can be progressive and may be assoc...
Objective: To develop comprehensive recommendations for the treatment of the various clinical manife...
Recent advances in the therapeutics of psoriatic arthritis (PsA) have provided more options to clini...
As erosive and deforming arthritis is present in 40% of patients with psoriatic arthritis (PsA), ear...
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease with heterogeneous clinical presen...
Psoriatic arthritis (PsA) is a chronic inflammatory condition with articular and extra-articular man...
Psoriatic arthritis (PsA) is a chronic inflamma-tory arthropathy of the peripheral joints, spine, an...
Psoriatic arthritis (PsA) is characteristically associated with a large spectrum of disorders, some ...
Skin and joint manifestations associated with psoriasis and psoriatic arthritis (PsA) can significan...
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, wh...